遗传学在外周动脉疾病管理中的作用
本文综述了外周动脉疾病(PAD)的遗传学研究,指出最大规模的全基因组关联研究(GWAS)已识别出19个全基因组显著位点,凝血因子V Leiden和循环脂蛋白相关基因与PAD发病相关,孟德尔随机化研究确认了吸烟、糖尿病和肥胖等因果危险因素,多基因风险评分可能改善疾病预测但需进一步验证。
要点
- 最大规模PAD的GWAS已识别19个全基因组显著位点,凝血因子V Leiden和循环脂蛋白相关基因与PAD发病相关。
- 孟德尔随机化研究确认吸烟、糖尿病和肥胖与PAD存在因果关联。
- 多基因风险评分可能改善疾病发生预测并早期识别高危患者,但需更多工作验证该方法。
核心结论
- 过去十年遗传流行病学增进了对PAD的理解,GWAS改善了对PAD遗传贡献的检测。
- 进一步遗传分析验证了危险因素,并可能为高危人群提供改进的筛查选择。
- 正在进行的慢性肢体威胁性缺血患者生物样本库研究及生物样本库入组中祖先多样性的增加,将允许进一步探索PAD的发病机制和进展。
研究设计与样本
- 综述:回顾了所有可获得的PAD GWAS研究,并检索这些研究的文献,总结了应用现有GWAS数据的相关文章。
主要发现
- 最大规模PAD的GWAS已识别19个全基因组显著位点,凝血因子V Leiden和负责循环脂蛋白的基因与PAD发生相关。
- 孟德尔随机化研究识别了吸烟、糖尿病和肥胖及许多其他性状的危险因素和因果关联。
- 基于蛋白质的孟德尔随机化还识别了与PAD发生率相关的循环脂质和凝血因子水平。
- 多基因风险评分可能改善疾病发生率预测并允许早期识别高危患者,但需更多工作验证该方法。
临床怎么用
- 原文未据此给出推荐。
局限性
- 多基因风险评分方法需更多工作验证。
- 原文报告需进一步研究以探索PAD的发病机制和进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genome wide association studies (GWAS) have allowed for a rapid increase in our understanding of the underlying genetics and biology of many diseases. By capitalizing on common genetic variation between individuals, GWAS can identify DNA variants associated with diseases of interest. A variety of statistical methods can be applied to GWAS results which allows for risk factor identification, stratification, and to identify potential treatments. Peripheral artery disease (PAD) is a common vascular disease that has been shown to have a strong genetic component. This article provides a review of the modern literature and our current understanding of the role of genetics in PAD. METHODS: All available GWAS studies on PAD were reviewed. A literature search involving these studies was conducted and relevant articles applying the available GWAS data were summarized to provide a comprehensive review of our current understanding of the genetic component in PAD. RESULTS: The largest available GWAS on PAD has identified 19 genome wide significant loci, with factor V Leiden and genes responsible for circulating lipoproteins being implicated in the development of PAD. Mendelian randomization (MR) studies have identified risk factors and causal associations with smoking, diabetes, and obesity and many other traits; protein-based MR has also identified circulating lipid and clotting factor levels associated with the incidence of PAD. Polygenic risk scores may allow for improved prediction of disease incidence and allow for early identification of at-risk patients but more work needs to be done to validate this approach. CONCLUSIONS: Genetic epidemiology has allowed for an increased understanding of PAD in the past decade. Genome-wide association studies have led to improved detection of genetic contributions to PAD, and further genetic analyses have validated risk factors and may provide options for improved screening in at-risk populations. Ongoing biobank studies of chronic limb threatening ischemia patients and the increasing ancestral diversity in biobank enrollment will allow for even further exploration into the pathogenesis and progression of PAD.
引用
- Biagetti G, Thompson E, O'Brien C, et al. The Role of Genetics in Managing Peripheral Arterial Disease. Ann Vasc Surg. 2024. PMID: 38960093. doi:10.1016/j.avsg.2024.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。